ArticleJournal of the American Society of Nephrology : JASN2017
IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury.
Open access · greenAbstract read
In one paragraph
Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.
0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
63 citing papers in PubMed, 96 citations in OpenAlex.
- Multiple organ dysfunction syndrome: molecular mechanisms and therapeutic strategies.Signal transduction and targeted therapy · 2026Review
- Acute kidney injury over the past decade: from definition evolution to pathogenesis insights and innovative therapeutic strategies.Cellular and molecular life sciences : CMLS · 2026Review
- ST2 Signaling Regulates Innate Immune Responses in Kidney Injury.bioRxiv : the preprint server for biology · 2026Article
- Organ cross-talk: molecular mechanisms, biological functions, and therapeutic interventions for diseases.Signal transduction and targeted therapy · 2026Review
- Suxiao Jiuxin Pill Promotes Post-Myocardial Infarction Cardiac Repair by Enhancing Regulatory T Cell Function via the ST2L Signaling Pathway.Journal of inflammation research · 2026Article
- ILC imbalance - a new piece in the gut-kidney axis puzzle.Frontiers in immunology · 2026Review
- Beyond the alarm: unveiling the multifaceted role of IL-33 in kidney disease.Frontiers in immunology · 2026Review
- Engineered Neuromedin U Promotes Type 2 Innate Immunity and Renoprotection in Acute Kidney Injury.Journal of the American Society of Nephrology : JASN · 2025Article
- Y665F variant of mouse Stat5b protects against acute kidney injury through transcriptomic shifts in renal gene expression.Scientific reports · 2025Article
- Innate Lymphoid Cells Are the Rheostat of Immune Response in the Kidney.Journal of cellular and molecular medicine · 2025Review
- Harnessing the biology of regulatory T cells to treat disease.Nature reviews. Drug discovery · 2025Review
- ST2 + T-Regulatory Cells as a Potential Immunotherapy Target for Kidney Fibrosis.Journal of the American Society of Nephrology : JASN · 2025Article
- A glimpse into the application of the immunomodulatory effect of IL-2 in systemic lupus erythematosus.Frontiers in medicine · 2025Review
- ST2 + T-Regulatory Cells in Renal Inflammation and Fibrosis after Ischemic Kidney Injury.Journal of the American Society of Nephrology : JASN · 2025Article
- Mechanisms Underlying the Impact of Interleukin Family on Acute Kidney Injury: Pathogenesis, Progression, and Therapy.Research (Washington, D.C.) · 2025Review
- The protective roles of integrin α4β7 and Amphiregulin-expressing innate lymphoid cells in lupus nephritis.Cellular & molecular immunology · 2024Article
- CD8 T cells induce the peritubular capillary rarefaction during AKI to CKD transition.International journal of biological sciences · 2024Article
- Renal Tubular CD24 Upregulation Aggravates Folic Acid Induced Acute Kidney Injury: A Possible Role for T Regulatory Cells Inhibition in Mice.Journal of personalized medicine · 2023Article
- Protective and pathogenic functions of innate lymphoid cells in transplantation.Clinical and experimental immunology · 2023Review
- Inhibition of ALKBH5 attenuates I/R-induced renal injury in male mice by promoting Ccl28 m6A modification and increasing Treg recruitment.Nature communications · 2023Article
3 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 2 institutions in 2 countries.
Marta E StremskaDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and.
Sheethal JoseDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and.
Vikram SabapathyDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and.
Liping HuangDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and.
Amandeep BajwaDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and.
Gilbert R KinseyDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and.
Poonam R SharmaBiomedical Engineering, University of Virginia, Charlottesville, Virginia.
Saleh MohammadDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and.
Diane L RosinDepartments of Pharmacology.
Mark D OkusaDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and.
Rahul SharmaDivision of Nephrology and Center for Immunity, Inflammation and Regenerative Medicine, Department of Medicine, and rs3wn@virginia.edu.
Laboratoire d’immunologie intégrative du cancer · FRUniversity of Virginia · US
Funding
Women's Oncology Program - WONP30CA044579 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Thomas P. Loughran · 1987 to 2026
$72.1MSphingolipids in Acute Kidney Injury and Disease ProgressionR01DK085259 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2010 to 2023
$5.0MLeukocyte Trafficking in Acute Renal FailureR01DK062324 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI OKUSA, MARK DOUGLAS · 2003 to 2016
$4.4MUltrasound for Non-Invasive Prevention of Acute Kidney InjuryR01DK105133 · NIDDK · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2015 to 2019
$2.4MThe TREX1 Pathway in Autoimmune DiseaseR01AI116725 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PERRINO, FRED W · 2016 to 2020
$1.9MRegulatory T Cells in Acute Kidney InjuryR01DK104963 · NIDDK · UNIVERSITY OF VIRGINIA · PI SHARMA, RAHUL · 2016 to 2020
$1.8MTargeting Treg for Therapy of Lupus GlomerulonephritisR01DK105833 · NIDDK · UNIVERSITY OF VIRGINIA · PI FU, SHU MAN, SHARMA, RAHUL · 2016 to 2019
$1.4MRegulatory T Cells as a Novel Therapeutic Agent/Target for Acute Kidney InjuryK01DK088967 · NIDDK · UNIVERSITY OF VIRGINIA · PI KINSEY, GILBERT R · 2010 to 2014
$593kSphingosine 1 phosphate receptors 1 and 3 as novel targets in transplantationK01DK091444 · NIDDK · UNIVERSITY OF VIRGINIA · PI BAJWA, AMANDEEP · 2012 to 2016
$579kMBF Bioscience and Zeiss Microscope System for Stereology and Tissue MorphologyS10RR026799 · NCRR · UNIVERSITY OF VIRGINIA · PI OKUSA, MARK DOUGLAS · 2010 to 2010
$278kNCI NIH HHS P30 CA044579NCRR NIH HHS S10 RR026799NIAID NIH HHS R01 AI116725NIDDK NIH HHS K01 DK088967NIDDK NIH HHS K01 DK091444NIDDK NIH HHS R01 DK062324NIDDK NIH HHS R01 DK085259NIDDK NIH HHS R01 DK104963NIDDK NIH HHS R01 DK105133NIDDK NIH HHS R01 DK105833
Abstract
CD4
Indexed as
Acute Kidney InjuryAnimalsCD4 Lymphocyte CountCell ProliferationCells, CulturedCisplatinCoculture TechniquesDoxorubicinInterleukin-1 Receptor-Like 1 ProteinInterleukin-2Interleukin-33KidneyMaleMiceRecombinant Fusion ProteinsReperfusion InjuryCisplatinDoxorubicinIl1rl1 protein, mouseIL233 fusion proteinInterleukin-1 Receptor-Like 1 ProteinInterleukin-2Interleukin-33Recombinant Fusion ProteinsAKIILC2InflammationIRInephrotoxicityTregs
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.